Evidence map›Paper›PMID 41737930›Full record

ArticleHeart rhythm O22026

Utilization and implementation of remote monitoring of cardiac implantable electronic devices in Australia and New Zealand: Adoption, workload, and integration challenges.

Brodie Sheahen, Edel O'hagan, Kenneth Cho, Kam Cheung Wong, Pierre Qian, Aravinda Thiagalingam, Graham Hillis, James Marangou, Derek Chew, Simone Marschner and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heart rhythm O2, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Brodie SheahenWestmead Applied Research Centre, The University of Sydney, Westmead Hospital, Westmead, NSW, Australia.
Edel O'haganWestmead Applied Research Centre, The University of Sydney, Westmead Hospital, Westmead, NSW, Australia.
Kenneth ChoWestmead Applied Research Centre, The University of Sydney, Westmead Hospital, Westmead, NSW, Australia.
Kam Cheung WongWestmead Applied Research Centre, The University of Sydney, Westmead Hospital, Westmead, NSW, Australia.
Pierre QianWestmead Applied Research Centre, The University of Sydney, Westmead Hospital, Westmead, NSW, Australia.
Aravinda ThiagalingamWestmead Applied Research Centre, The University of Sydney, Westmead Hospital, Westmead, NSW, Australia.
Graham HillisRoyal Perth Hospital, Cardiology Department, Perth, WA, Australia.
James MarangouRoyal Perth Hospital, Cardiology Department, Perth, WA, Australia.
Derek ChewCardiology Department, Victorian Heart Hospital, Clayton, VIC, Australia.
Simone MarschnerWestmead Applied Research Centre, The University of Sydney, Westmead Hospital, Westmead, NSW, Australia.
Haeri MinWestmead Applied Research Centre, The University of Sydney, Westmead Hospital, Westmead, NSW, Australia.
Liliana LaranjoWestmead Applied Research Centre, The University of Sydney, Westmead Hospital, Westmead, NSW, Australia.
Clara ChowWestmead Applied Research Centre, The University of Sydney, Westmead Hospital, Westmead, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Remote monitoring (RM) of cardiac implantable electronic devices (CIEDs) reduces health care visits and improves clinical outcomes, but its use and service models are poorly characterized. Objective: This study aimed to examine the current landscape of CIED RM in Australia and New Zealand, including the prevalence of CIED and RM use, care models for RM data management, and infrastructure and resource requirements. Methods: A cross-sectional study was conducted using surveys of CIED clinics in Australia and New Zealand and analysis of deidentified CIED industry data. Data were obtained from public and private clinics and all 5 major CIED manufacturers. Results: Operational data were obtained from 50 clinics and implant/RM distribution data from all 5 manufacturers. From 2019 to 2023, total CIED implantations increased by 10.2% (125.9-138.8 per 100,000 people), whereas RM transmitter distribution rose 55.8% (75.5-117.6 per 100,000 people). In 2023, RM use was highest in remote (88.4%) and rural regions (85.3%) compared with regional (73.1%) and metropolitan (80.3%) areas. From survey data, the median clinic patient load was 1303 patients (interquartile range 1820) per year. On average, 30.2% of clinic workload (standard deviation 21.8%) was dedicated to managing RM alerts, primarily by cardiac physiologists (90.5%). The mean interval between scheduled in-person CIED follow-ups was longer for RM patients than non-RM patients (10.0 vs 7.2 months; Conclusion: This study provides the first comprehensive analysis of CIED RM service use, offering insights to inform future RM care models and the development of other virtual care systems using remote patient data.

Indexed as

Cardiac implantable electronic devicesCare modelsHealth care servicesImplantation ratesRemote monitoring

Identifiers

PMID41737930
PMCPMC12925928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.